Inogen Inc (INGN) : Inogen Inc (INGN) had a healthy money flow of $5.78 million into the stock during the Thursdays trading session. The value of bullish trades on upticks was $8.32 million, whereas, investors only sold shares worth $2.54 million on downticks. The stock closed the day with an up-down ratio of 3.27.The money flow in the block trades to the tune of $5.21 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $5.21 million worth of transactions were on upticks. Inogen Inc (INGN) stock slid $0.4 intraday and traded at 51.35, a change of -0.77% over previous days close. However, for the week, the company shares are -1.08% compared to previous weeks close.
The stock has recorded a 20-day Moving Average of 4.88% and the 50-Day Moving Average is 6.82%. Shares have rallied 17.45% from its 1 Year high price. On Sep 14, 2015, the shares registered one year high at $55.98 and the one year low was seen on Feb 8, 2016. The 50-Day Moving Average price is $48.68 and the 200 Day Moving Average price is recorded at $42.18.
Inogen Inc (NASDAQ:INGN): The stock opened at $51.98 on Thursday but the bulls could not build on the opening and the stock topped out at $52.00 for the day. The stock traded down to $50.66 during the day, due to lack of any buying support eventually closed down at $51.35 with a loss of -0.77% for the day. The stock had closed at $51.75 on the previous day. The total traded volume was 320,641 shares.
In an insider trading activity, Huggenberger Raymond, director officer (CEO) of Inogen Inc, unloaded 20,747 shares at an average price of $47.89 on June 16, 2016. The total amount of the transaction was worth $993,574, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company offers Inogen One systems, such as Inogen One G3 and G2 that concentrate the air around the patients to offer a single source of supplemental oxygen. The Inogen One G3 and G2 have up to 4.5 and five hours of battery life respectively. The Companys Inogen One G2 is effective for nocturnal use.